aimosti

EU-sovereign · whole-genome re-analysis · made in Finland

Your genome doesn't change.
What we know about it does.

Aimosti is a whole-genome re-analysis service. Bring the DNA data you already own — we match it to current clinical and research databases and tell you what the evidence says about each variant: attributed, versioned, never a diagnosis. When that evidence shifts, we re-read your file and flag what changed.

From €79 for a chip file (23andMe · AncestryDNA · MyHeritage), or €119 for whole-genome. One-time, yours to keep.

We keep your report current. Own every report forever. €29/yr keeps it updating. Stop anytime and you keep the last one. Never rented back to you.

Your data stays in Finland. Encrypted in transit, never sold, deleted on demand.

Restated from ClinVar·ACMG SF·CPIC·GWAS Catalog·gnomAD·PhyloTree

We restate the science. We never originate it.

What Aimosti does

  • Re-analyses variant data you already own (WGS)
  • Restates ClinVar, ACMG SF, CPIC, GWAS Catalog & PhyloTree, pinned to a version
  • Shows evidence and effect on two separate axes, never one score
  • Names the gaps: what a variant file cannot tell you
  • Re-runs as the databases improve (subscription)

What Aimosti never does

  • Take a sample, sequence, test, or diagnose
  • Invent a gene or variant association on our own authority
  • Collapse weak evidence into a confident-looking number
  • Sell, share, or mine your data
  • Report MTHFR or APOE as a clinical finding (we explain why)

Everything a variant file can tell you.

Each module is anchored to an authoritative, version-pinned source. The speculative modules are walled off from the clinical ones, so curiosity never wears the authority of settled science.

ClinVar / ACMG SF v3.3

Clinical findings

Pathogenic / likely-pathogenic variants in an established actionable-gene panel, framed as personal risk, never a verdict.

ACMG Tier 3 + ACOG carrier panel

Carrier status

A recessive-lens look at carrier variants in your file, for family planning, with the un-callable conditions named.

CPIC guidelines

Pharmacogenomics

How your genotype may affect specific medicines, restating CPIC, to discuss with a prescriber.

GWAS Catalog

Traits

Benign, well-replicated, genome-wide-significant traits that clear a strict evidence gate. No SNPedia folklore.

PhyloTree

Ancestry · maternal & paternal

Your deep maternal and paternal lines as global haplogroups, one thread of your tree, never a "percent ancestry" figure.

below the firewalllabelled exploratory, never clinical
Expanded · exploratoryEmerging research

Frontier

Dozens of readings from the interesting edge of the science (alcohol-flush and caffeine metabolism, the natural short-sleeper genes, longevity curios, even the “warrior gene” myth set straight), each labelled by how much it really weighs.

Just for funSpeculative · curiosity only

The Fringe

The playful gene-quirks people love to look up (why coriander can taste of soap, red hair, spicy-food tolerance, even the genetics of rage at chewing sounds), labelled, bluntly, as for curiosity only.

See every gene, condition & trait we examine, by name →

For the biohackers. Straight about the uncertainty.

Everyone else either hides the speculative stuff or sells it as gospel. We do the opposite: dozens of the variants you actually want to see (the short-sleeper genes, alcohol-flush metabolism, and the famous “warrior gene” and serotonin “depression gene” we show are over-sold), each wearing a blunt evidence tier, from replicated down to contested. The honesty is the product.

How Frontier is gated →

22:19,963,748 · rs4680
Mixed evidence

COMT: “warrior / worrier”

Your genotype · A/A → Worrier (slower clearance)

Slower prefrontal dopamine clearance, associated on average with better working memory when calm and more reactivity under stress. A U-shaped, context-dependent effect, not a label. Not medical.

A reading instrument, not a dashboard.

Every finding shows its variant, your genotype, the source's own confidence, and how common it is, with plain-language explainers a tap away. No gamified scores, no dark patterns.

Open a full sample report →

aimosti · report.pdf
Evidence ★★★★ · Effect Actionable

Factor V Leiden thrombophilia

F5 · 1:169,549,811 · rs6025 · heterozygous · ClinVar Pathogenic. A clotting-risk variant worth knowing before surgery, pregnancy or the pill. Confirm with a clinician and a validated test before acting. Never a diagnosis.

re-analysis · what changed

+ NEW ClinVar reclassified a variant in your file to Likely pathogenic.

~ UPDATED A Frontier association gained a replication cohort.

· STABLE Everything else unchanged since your last report.

Your genome can tell more.
The science isn't settled.

Databases improve every month. Keep only your small normalised variant file with us and we silently re-match it as the literature moves, then tell you plainly what changed. Withdraw any time; your last report is always yours.

≈ €29 / year · raw reads never retained

Your most personal data, governed like it matters.

  • EU ONLYStored and processed in FinlandStored in servers in Helsinki. Your genome never leaves the EU.
  • ART. 9Explicit, revocable consentGenetic data is special-category under GDPR. One explicit consent processes your file and produces your report; research and marketing stay separate and optional, every choice withdrawable, auditable, and versioned.
  • CRYPTOEncrypted, never soldEncrypted in transit. We don't sell, share, or mine your data, ever.
  • DELETEDeleted on demandRaw reads are purged after analysis by default. Delete everything with one request.

Read the full data & security story →

One fair price. Yours to keep, kept live if you choose.

Pick where to start. Every report is a one-time purchase you own forever. To keep your report current as the science moves, add the re-analysis subscription for €29/yr. Compare every plan in full →

Genotyping chip

Chip report

€79 one-time

For 23andMe, AncestryDNA and similar array exports: everything your chip can call, fully attributed. Carrier status and the full clinical panel need whole-genome data.

  • Clinical findings your array covers
  • Pharmacogenomics for the genes your chip typed
  • Traits, ancestry & the Frontier module
  • Plain-language explainers & PDF
See the chip report

Stay current. Add the €29/yr re-analysis subscription to keep it re-matched as the science moves. Cancel anytime.

Grow into it: upgrade to the full WGS report for €40 whenever you’re ready.

Most popular

Full report (WGS)

€119 one-time

Every module over your whole-genome file: the deepest read of the genome you already own.

  • Clinical, carrier, PGx, traits, ancestry
  • Frontier exploratory module
  • Plain-language explainers & PDF
  • Pinned, attributed sources
Get my report · €119

Stay current. Add the €29/yr re-analysis subscription to keep your report re-matched as the science moves. Cancel anytime.

From your aligned reads

Deep Read

€149 one-time

A 29-gene pharmacogenomic panel (CYP2D6 + 28 more) from your aligned reads, with a per-gene callability map of exactly what we examined.

  • 29-gene pharmacogenomic panel
  • CYP2D6 star-allele resolution
  • Per-gene callability, measured
  • Reads deleted immediately after
Deep Read pricing

Stay current. Add the €29/yr re-analysis subscription to keep your living report re-matched. Or prepay Deep Read with the WGS bundle to save.

Why not the €23 option?

Promethease and Genetic Genie read the same public databases we do. The difference is time. They hand you a report frozen on the day you run it, built from the few thousand positions a genotyping chip happens to type. We read your whole genome where you have it, attribute every finding to the guideline it came from, and re-read your file as those guidelines change. You buy the careful version once, and it stays current. You keep it either way.

Named services are described from their public product pages; features change and we don't speak for them. Cheaper isn't the problem. What "frozen the day you ran it" costs you three years later is.

Common questions

Do you sequence my DNA?

No. Aimosti never takes a sample or sequences anything. You bring whole-genome data you already had produced; we re-analyse the variant file.

Is this a medical test or diagnosis?

No. Every finding is a literature match against public databases, information to confirm with a clinician and a validated gene test, never a diagnosis or medical advice.

What files do you accept?

A whole-genome gVCF gives the most complete report: it records which regions your sequencing covered, so "not found" can mean "examined and clear", not just absent. A plain VCF also gives the full report, read as variant-only. Nebula Genomics, Dante Labs, Sequencing.com and the like are good to go — upload the gVCF if your provider offers one. Chip raw data from 23andMe, AncestryDNA or MyHeritage works too, for a lighter report (traits, pharmacogenomics and ancestry); clinical findings and carrier status need a sequenced genome.

Where does my data live?

Stored in Finland (Helsinki), never leaving the EU, never sold, deleted on demand. More →

All questions →

The genome you already own has more to say.

One living report, many modules. Read in Finland, attributed to the source, yours to keep.

Get your report · €119